NewLeaf Symbiotics closes $17 mln Series B
NewLeaf Symbiotics has closed a $17 million Series B round of financing. Otter Capital led the round and was joined by existing investors RockPort Capital, Open Prairie Ventures and Pangaea Ventures. The company is a St Louis, Missouri-based agricultural bio company focused on the commercialization of beneficial plant bacteria.
17 September 2014•2 mins read
